Primary study · included by 1 review
Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer.
Watanabe 2010 · Watanabe Tomoko, Ishihara Masashi, Matsuura Katsuhiko, et al. · International journal of cancer · 2010
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Severe (Grade 3-4) radiation-induced oral mucositis Topical zinc mouthwash or rinse vs Placebo, standard care or no treatment · During radiotherapy | RR 0.16 [0.05, 0.49] | 2 studies · 64 participants | Moderate |
1 including review in total.